Showing 1 - 3 results of 3 for search 'Lisa Svartdal Normann', query time: 0.02s Refine Results
  1. 1
    Serglycin Is Involved in TGF-β Induced Epithelial-Mesenchymal Transition and Is Highly Expressed by Immune Cells in Breast Cancer Tissue

    Serglycin Is Involved in TGF-β Induced Epithelial-Mesenchymal Transition and Is Highly Expressed by Immune Cells in Breast Cancer Tissue by Marta Tellez-Gabriel, Xavier Tekpli, Trine M. Reine, Beate Hegge, Stephanie R. Nielsen, Meng Chen, Line Moi, Line Moi, Lisa Svartdal Normann, Lisa Svartdal Normann, Lill-Tove R. Busund, Lill-Tove R. Busund, George A. Calin, George A. Calin, Gunhild M. Mælandsmo, Gunhild M. Mælandsmo, Maria Perander, Achilleas D. Theocharis, Svein O. Kolset, Erik Knutsen, Erik Knutsen

    Published 2022-04-01
    Get full text
    Article
  2. 2
    High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer.

    High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer. by Lisa Svartdal Normann, Mads Haugland Haugen, Vesa Hongisto, Miriam Ragle Aure, Suvi-Katri Leivonen, Vessela N Kristensen, Andliena Tahiri, Olav Engebraaten, Kristine Kleivi Sahlberg, Gunhild Mari Mælandsmo

    Published 2023-01-01
    Get full text
    Article
  3. 3
    Liver X receptors induce antiproliferative effects in basal‐like breast cancer

    Liver X receptors induce antiproliferative effects in basal‐like breast cancer by Mads Haugland Haugen, Hedda von der Lippe Gythfeldt, Eivind Valen Egeland, Lisa Svartdal Normann, Abhilash D. Pandya, Lise‐Lotte Vedin, Siri Juell, Ellen Tenstad, Geir Frode Øy, Alexandr Kristian, Elisabetta Marangoni, Therese Sørlie, Knut Steffensen, Gunhild Mari Mælandsmo, Olav Engebraaten

    Published 2023-10-01
    Get full text
    Article

Search Tools: